Get started
Work

GAS6 expression identifies high-risk adult AML patients: potential implications for therapy

Year: 2013
Type: article
Study design: Observational Study
Source: Leukemia
DOI: 10.1038/leu.2013.371
Authors: S P Whitman, J Kohlschmidt, K Maharry, S Volinia, K Mrózek, D Nicolet, S Schwind, H Becker, K H Metzeler, J H Mendler, A-K Eisfeld, A J Carroll, B L Powell, T H Carter, M R Baer, J E Kolitz, I-K Park, R M Stone, M A Caligiuri, G Marcucci, C D Bloomfield
Institutions: The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Mayo Clinic, Alliance for Clinical Trials in Oncology, The Ohio State University, University of Alabama at Birmingham, Wake Forest Baptist Comprehensive Cancer Center, Wake Forest University, University of Iowa, University of Maryland, Baltimore, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, North Shore University Hospital, Dana-Farber Cancer Institute
Language: English
Subfield: Hematology
Field: Medicine
Open Access status: green
Awards: G1069145923, Molecular characterization of normal cytogenetics AML in older patients, Alliance Statistics and Data Management Center, G20154349, G2279923822, ITSC for Leukemia: Novel Molecular Strategies for NCTN: "Individualized" Therapie, Experimental Therapeutics of Leukemia, G2646040624, G2647518335, G2714647962, Cancer and Leukemia Group B Statistical Center, Oncology Training Grant, Cancer and Leukemia Group B - Leukemia Correlative Sciences, G6480384664, Cancer and Leukemia Group B, G7338240445, Cancer and Leukemia Group B - The Ohio State University, Cancer and Leukemia Group B Human Specimen Repositories, Cancer Center Support Grant, G973482110
OpenAlex ID: W2016490796
FWCI: 4.337
Cites: 69
Cited by: 57
Related to: 10